VOD Congrès 2021
Thursday, 30th September
Friday, 1st October
Thursday, 30th September
BRAINMETS PARIS 2021 Part 1
Welcome address
Philippe Métellus (FR)
Opening lecture
John Adler (US)
Basic science & translational research in brain metastases - Microenvironment
Adrienne Boire (US)
Challenges in clinical practice (1): spinal cord metastatic compression and intrinsic medullary tumors - Surgery
Manfred Westphal (DE)
Challenges in clinical practice (1): spinal cord metastatic compression and intrinsic medullary tumors - Radiotherapy
Frédéric Dhermain (FR)
Challenges in clinical practice (2): cancer of unknown primary (CUP) - How do I manage?
Riccardo Soffietti (IT)
BRAINMETS PARIS 2021 Part 2
Controversial treatments for CNC metastases - Pro surgery first
Philippe Métellus (FR)
Fluorescence guided surgery for brain metastases? Shared experience and clinical evidence level
Philippe Métellus (FR)
IO alone versus IO + SRT in newly diagnosed melanoma brain metastases - Pro :
Dieta Brandsma (NL)
IO alone versus IO + SRT in newly diagnosed melanoma brain metastases - Contra :
Giuseppe Minniti (IT)
BRAINMETS PARIS 2021 Part 3
Pharma symposium Brain metastases in HER2+ MBC: Overcoming the unmet medical need
Welcome and introductions
Emilie Le Rhun (CH)
Current and future treatment strategies
Volkmar Müller (DE)
Tucatinib’s role in managing brain metastases: HER2CLIMB
Thomas Bachelot (FR)
Q&A and close
BRAINMETS PARIS 2021 Part 4
Controversies in brain metastases patient assessment
Norbert Galldiks (DE)
WBRT with hippocampal sparing versus radiosurgery - Pro :
Agnès Tallet (FR)
WBRT with hippocampal sparing versus radiosurgery - Contra :
Frédéric Dhermain (FR)
WBRT with hippocampal sparing versus radiosurgery - Discussion
Interactive case reports with electronic voting system - Case 1
Philipp Karschnia (DE)
Interactive case reports with electronic voting system - Case 3 :
Sophie Bockel (FR)
Keynote lecture Perspectives in breast cancer brain metastases
Nancy Lin (US)
The new EANO ESMO guidelines on brain metastases
Emilie Le Rhun (CH)
Friday, 1st October
BRAINMETS PARIS 2021 Part 5
Satellite Symposium - Spinal metastases with intraoperative scanner?
Kaissar Farah (FR)
Selected oral presentations - Checkpoint-inhibition therapy for brain metastases from lung cancer
Philipp Karschnia (DE)
Selected oral presentations - Adaptation of colorectal cancer cells to the brain microenvironment: The role of IRS2
Inbal Greenberg (IS)
Selected oral presentations - Selection of intrinsically chemoresistant tumor cells
Rebeca Uceda (NL)
Selected oral presentations - T lymphocyte IFN- enhances the ability of breast cancer cells
Dana Mustafa (NL)
Selected oral presentations - Impact of Tucatinib on Progression Free Survival in Patients with HER2+
Thomas Bachelot (FR)
Clinical impact of MRI screening for brain metastases in resected stage III melanoma
Sophie Derks (NL)
Selected oral presentations - Detection of circulating tumor cells in cere-brospinal fluid for patients
Amélie Darlix (FR)
Selected oral presentations - Evaluation of predictive markers for the patterns of metastatic disease
Janina Wolf (NL)
Selected oral presentations - Brain metastases – Impact of extent of resection
Rebecca Rootwelt Winther (NO)
Highlights 2019-2020 & 2021! - Imaging
Norbert Galldiks (DE)
Highlights 2019-2020 & 2021! - Neurosurgery
Philippe Métellus (FR)
BRAINMETS PARIS 2021 Part 6
Highlights 2019-2020 & 2021! - What’s hot in melanoma CNS metastases?
Caroline Robert (FR)
Highlights 2019-2020 & 2021! - What’s hot in breast cancer CNS metastases?
Benjamin Verret (FR)
Highlights 2019-2020 & 2021! - What’s hot in lung cancer CNS metastases?
Rolf Stahel (CH)
Highlights 2019-2020 & 2021! - Stereotactic radiation in BM management
Frédéric Dhermain (FR)
Highlights 2019-2020 & 2021! - What’s hot in leptomeningeal metastases?
Emilie Le Rhun (FR)
Awards – Best communication and poster
Concluding remarks
Frédéric Dhermain (FR)
BRAINMETS PARIS 2021 Part 1
BRAINMETS PARIS 2021 Part 3
Pharma symposium Brain metastases in HER2+ MBC: Overcoming the unmet medical need
Keynote lecture Perspectives in breast cancer brain metastases
Nancy Lin (US)
